REVISION IMPLANT

Active

Public limited companyfounded 2019active for 6 yearsBlandenstraat 31, 3053 Oud-Heverlee, BelgiumKBO/BCE: BE 0740.519.675

Summary

REVISION IMPLANT has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €387,038 and a net result of -€36,000. Equity remains stable across the filed financial years (±1.6% per year). Its solvency ranks better than 59% of 810 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

REVISION IMPLANTActiveChecked score 93/100

Risk analysis Report Compare

Activity

Other professional, scientific and technical activities

NACE 74999Other research and development on natural sciences NACE 72109

1 site

Size

€752,620total assets 2025

Staff: 5.3 FTE
Equity: €387,038
Loss: -€36,000

Turnover not published (abbreviated format)

Financial health

93 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

Largest shareholder: BOO SERVICES · 33.33%
Board: 6 members

2025 accounts 44 days early2 of 4 deeds summarised

Why 93raises riskLoss of €36,000, the second in a row (financial year 2025)lowers riskLiquidity: current ratio 6.25, cash €686,197Sector: Other professional, scientific and technical activities (NACE 74)Size: total assets €752,620Show the evidence

Checked score

Score 2025

93 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 47% of its sector peers (NACE 74, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 76-24

equity 51.4% of total assets

Liquidity 97-3

short-term debt 15.4% · cash 91.2%

Profitability 26+26

return on assets -4.8%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (5,417 companies, NACE 74, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.2%▲ +0.1 percentage points vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.3%▲ +0.1 percentage points vs 08-2026highest value 10-2026: < 0.1%▼ -0.3 percentage points vs 09-2026lowest value

Credit of up to €35,000 on 30-day terms is acceptable

Liquidity ample (current ratio 6.25, compared with 10.73 in 2024, above the usual 1.5; short-term debt: 15.4% and cash: 91.2% of total assets), and 48.6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 74, micro): better than 53% on solvency, 91% on liquidity, 21% on profitability and 22% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Liquidity: current ratio 6.25, cash €686,197

NBB · annual accounts

Sector: Other professional, scientific and technical activities (NACE 74)

KBO

Size: total assets €752,620

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Loss of €36,000, the second in a row (financial year 2025)

NBB · annual accounts

Persistent losses

Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.

NBB · annual accounts 2025

Net result per financial year

202122232425

2020 to 2025 · latest year -€36,000

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.

NBB · 6 filings

Deviation from the deadline

2025

44 days early

2024

63 days early

2023

46 days early

2022

57 days early

2021

33 days early

2020

68 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 52 days before the deadline; the sector median (NACE 74) for financial year 2024 is 3 days before the deadline, and 38% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 June (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

25-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

17-06-2026 Annual accounts filedfinancial year 2025 · abbreviated…
04-06-2026 Resignations: CEYSSENS Frederik, PEETERS Jasmine and…Appointments: CEYSSENS Frederik, PEETERS Jasmine…
29-05-2025 Annual accounts filedfinancial year 2024 · abbreviated…

Key points

Risk: 6 loss-making years in a rowloss financial year 2025 -€36,000 View
Positive: Result rose in 2025from -€293,396 to -€36,000 ▲ 87.7% View
Caution: Among the weakest 11% on net resultsector median €12,727 · 808 companies -€36,000 View
New directorslatest change 04-06-2026 · 6 in office 6 joined View
Positive: Always filed on timeaccounts within the deadline every year 6 years View
EU research moneyEU contribution €1.6m View

By topic

Financials

Financial year: 2025
Total assets: €752,620
Loss: -€36,000
Solvency: 51.4%

Turnover▼ 88.9%

Net result

20202024

Go to Financials

Board & ownership

Board: 6 members
Largest shareholder: BOO SERVICES · 33.33%

Dagda Ventures BVDirector
Frederik CeyssensDirector
PEETERS JasmineDirector
SCHELLES MaartenDirector
VAN DEN BOSSCHE JohanDirector

and 1 other director

Go to Board & ownership

Timeline

Events: 10
Since: 2021
Next accounts: by 31-07-2027

31-12-2024Weakest financial year
16-09-2024Resignation: Erwin Dekeyser (director)
15-06-2024Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Public limited company
Activity: Other professional, scientific and technical activitiesNACE 74999
Founded: 23-12-2019
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 18

Purpose: “Onderzoek naar nieuwe technologieën, uitvindingen, nemen en handelen in patenten…” (deed in Dutch)

Go to Articles of association

Key facts about REVISION IMPLANT

What is the company number of REVISION IMPLANT?: 0740.519.675. In Belgium the VAT number is the company number with BE in front: BE 0740.519.675.
Where is REVISION IMPLANT based?: The registered office is at Blandenstraat 31, 3053 Oud-Heverlee.Company details
What does REVISION IMPLANT do?: According to the KBO register, the main activity is other professional, scientific and technical activities (NACE 74999).
What is the legal form of REVISION IMPLANT?: Public limited company (NV).
When was REVISION IMPLANT founded?: On 23-12-2019.
Is REVISION IMPLANT still active?: Yes, REVISION IMPLANT is an active enterprise in the KBO register.
How many employees does REVISION IMPLANT have?: On average 5.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of REVISION IMPLANT?: €6,670 in financial year 2024, according to the filed annual accounts.
Is REVISION IMPLANT profitable?: In financial year 2025, REVISION IMPLANT made a loss of €36,000.
Where can I find the annual accounts of REVISION IMPLANT?: REVISION IMPLANT filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of REVISION IMPLANT due?: By 31-07-2027, for financial year 2026.Timeline